buthionine sulfoximine has been researched along with tretinoin in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (14.29) | 18.2507 |
2000's | 6 (85.71) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J | 1 |
Davey, MW; Davey, RA; Kidman, AD; Su, GM | 1 |
Cai, X; Chen, G; Chen, S; Huang, X; Jia, P; Shen, Y; Wang, L; Wang, Z; Yang, J; Yu, Y; Zhang, X; Zhou, L; Zhou, Y | 1 |
Cai, X; Huang, X; Zhou, Y | 1 |
Mansfield, K; Nemelivsky, YV; Rajpurohit, R; Shapiro, IM; Teixeira, CC | 1 |
Alonso-Varona, A; Bilbao, P; Castro, B; del Olmo, M; Iglesias, A; Palomares, T | 1 |
7 other study(ies) available for buthionine sulfoximine and tretinoin
Article | Year |
---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection | 2009 |
Development of extended multidrug resistance in HL60 promyelocytic leukaemia cells.
Topics: Antimetabolites, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Buthionine Sulfoximine; Drug Resistance, Multiple; Epirubicin; Humans; Leukemia, Promyelocytic, Acute; Methionine Sulfoximine; Tretinoin; Tumor Cells, Cultured; Verapamil; Vinblastine | 1994 |
Arsenic trioxide induces multiple myeloma cell apoptosis via disruption of mitochondrial transmembrane potentials and activation of caspase-3.
Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Buthionine Sulfoximine; Caspase 3; Caspases; Dose-Response Relationship, Drug; Enzyme Activation; Humans; Membrane Potentials; Mitochondria; Multiple Myeloma; Oxides; Tretinoin; Tumor Cells, Cultured | 2001 |
[Mechanisms of arsenic trioxide-induced apoptosis in myeloma cells].
Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Buthionine Sulfoximine; Cell Division; Dithiothreitol; Drug Interactions; Humans; Interferon-alpha; Multiple Myeloma; Oxides; Tretinoin; Tumor Cells, Cultured | 2001 |
Maturation-dependent thiol loss increases chondrocyte susceptibility to apoptosis.
Topics: Acetylcysteine; Alkaline Phosphatase; Animals; Apoptosis; Buthionine Sulfoximine; Cell Differentiation; Cell Survival; Cells, Cultured; Chick Embryo; Chondrocytes; Collagen Type II; Collagen Type IX; Cysteine; Fluorescent Dyes; Gene Expression; Glutathione; Growth Plate; Nitric Oxide; Osteopontin; Oxidation-Reduction; Oxidative Stress; Sialoglycoproteins; Sulfhydryl Compounds; Tretinoin | 2003 |
Influence of the level of gamma-glutamyltranspeptidase activity on the response of poorly and moderately differentiated rhabdomyosarcoma cell lines to all-trans-retinoic acid.
Topics: Animals; Antineoplastic Agents; Apoptosis; Buthionine Sulfoximine; Cell Differentiation; Cell Proliferation; Drug Combinations; Female; gamma-Glutamyltransferase; Glutathione; Rats; Rats, Wistar; Reactive Oxygen Species; Rhabdomyosarcoma; Transplantation, Homologous; Tretinoin; Tumor Burden; Tumor Cells, Cultured | 2006 |